Actively Recruiting
Pregnancy Surveillance Program of Patients Exposed to Epidiolex/Epidyolex During Pregnancy
Led by Jazz Pharmaceuticals · Updated on 2026-04-13
50
Participants Needed
1
Research Sites
421 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The purpose of this study is to evaluate pregnancy-related health outcomes in participants who are exposed to Epidiolex/Epidyolex during pregnancy and their infant up to 12 months of life.
CONDITIONS
Official Title
Pregnancy Surveillance Program of Patients Exposed to Epidiolex/Epidyolex During Pregnancy
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients with exposure to at least 1 dose of Epidiolex/Epidyolex during the 13 days prior to their last menstrual period or at any time during pregnancy
- Verbal or written informed consent to participate
You will not qualify if you...
- Patients exposed to a non-regulatory approved cannabidiol (CBD) product during pregnancy who do not also have exposure to Epidiolex during the 13 days prior to their last menstrual period or during pregnancy
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
United Biosource LLC
Morgantown, West Virginia, United States, 26508
Actively Recruiting
Research Team
C
Clinical Trial Disclosure & Transparency
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here